SHPT is a common complication of chronic kidney disease (CKD), triggered by hyperphosphatemia, hypocalcemia, and low levels of 1,25OH2D. SHPT is characterized by parathyroid gland hyperplasia that leads to reduced expression of the vitamin D receptor and CaSR, and chronically elevated PTH secretion. Here, CASR is linked to hyperphosphatemia.